How many studies have been conducted on Tumor Necrosis Factor Alpha?

BiohacksAI has indexed 300 PubMed studies on Tumor Necrosis Factor Alpha, including 1 randomized controlled trials (RCTs). 37% of studies involve human subjects.

What are the main research areas for Tumor Necrosis Factor Alpha?

The primary research domains for Tumor Necrosis Factor Alpha are 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Tumor Necrosis Factor Alpha

Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 46.1

Research Domains

Tumor Necrosis Factor Alpha has been studied across 21 research domains including 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity, 🦴 Bone & Joint, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 99% of studies addressing this area.

Loading evidence profile...

This evidence profile for Tumor Necrosis Factor Alpha is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.